ScreenerHero

EVFMEvofem Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · evofem.com
0.0075USD-1.32%Mkt Cap: 993975 $P/E: —

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a ho…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap993.98K $
Enterprise Value—
Revenue (TTM)—
Gross Profit15.57M $
Net Income (TTM)391.00K $
Revenue/Share0.1630 USD
Last Price0.0075 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30048L2034
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.01
EPS (TTM)-0.11
EPS (Forward)-0.55
52W Range
0.001034% of range0.0200
52W High0.0200 USD
52W Low0.0010 USD
Profitability
Gross Margin77.12%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin1.94%
ROE-0.53%
ROA1.93%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.99M $
CapEx (TTM)5.00K $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.73
Current Ratio—
Quick Ratio—
Book Value/Sh-0.5870 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2018
Splits
Last Split1:125
Split DateMay 18, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.132.53M
Float—
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float11.01%
Short % Out.10.98%
Shares Short69.46K
Short (prev mo.)142.57K
Technical
SMA 500.0081 (-7.6%)
SMA 2000.0087 (-14.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)91.19K
Avg Vol (10d)319.83K
Technical Indicators
RSI (14)48.8
MACD-0.0001
MACD Signal-0.0001
MACD Hist.-0.0000
BB Upper0.0086 USD
BB Middle0.0076 USD
BB Lower0.0066 USD
BB Width26.21%
ATR (14)0.0009 USD
Vol Ratio (20d)0.24x